These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11754196)

  • 1. Steroid treatment for myasthenia gravis: steroids have an important role.
    Bedlack RS; Sanders DB
    Muscle Nerve; 2002 Jan; 25(1):117-21. PubMed ID: 11754196
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroid treatment for myasthenia gravis: steroids are overutilized.
    Rivner MH
    Muscle Nerve; 2002 Jan; 25(1):115-7. PubMed ID: 11754195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current therapy of myasthenia].
    Zumstein V; Regli F
    Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thymectomy in the management of myasthenia].
    Balzereit F; Bay V; Otto H; Rittmeyer P; Sobirey C
    Z Neurol; 1972; 201(2):136-59. PubMed ID: 4112645
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of juvenile myasthenia gravis].
    Arroyo HA
    Medicina (B Aires); 2019; 79 Suppl 3():71-76. PubMed ID: 31603848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular myasthenia gravis patients following the administration of tacrolimus and steroids.
    Omata T; Fukui K; Kodama K; Watanabe Y; Aoyama H; Fujii K; Shimojo N
    J Neurol Sci; 2019 Jan; 396():30-32. PubMed ID: 30399462
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of myasthenia gravis.
    Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy in myasthenia gravis].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):726-8. PubMed ID: 4325239
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversies about the treatment of myasthenia gravis.
    Rowland LP
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):644-59. PubMed ID: 7400825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ocular symptoms in myasthenia gravis.
    Bhanushali MJ; Wuu J; Benatar M
    Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of myasthenia gravis.
    Arora Y; Li Y
    Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive therapy of myasthenia gravis.
    Szobor A; Petrányi G
    Acta Med Acad Sci Hung; 1970; 27(4):397-411. PubMed ID: 5314027
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis.
    De Feo LG; Schottlender J; Martelli NA; Molfino NA
    Muscle Nerve; 2002 Jul; 26(1):31-6. PubMed ID: 12115946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic considerations in myasthenia gravis].
    Vejvalka J
    Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT; Patwa HS; Knorr AM; Lesser RL; Goldstein JM
    J Neurol Sci; 2004 Feb; 217(2):131-3. PubMed ID: 14706214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of severe myasthenia gravis with immunosuppressive agents.
    Mertens HG; Balzereit F; Leipert M
    Eur Neurol; 1969; 2(6):321-39. PubMed ID: 4185500
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel therapies target myasthenia gravis.
    Hampton T
    JAMA; 2007 Jul; 298(2):163-4. PubMed ID: 17622589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of myasthenia].
    Fève JR
    Rev Prat; 1988 Oct; 38(22):1541-5. PubMed ID: 3206137
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of myasthenia gravis].
    Jerusalem F
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current results of the treatment of pseudoparalytic myasthenia gravis with immunosuppressive agents].
    Ricken D
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):237-41. PubMed ID: 4341360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.